Creotech Instruments continues to invest in its growth strategy targeting both the spacetech and quantum computing markets. The first report under IFRS, Q123 results saw positive development of revenues but higher costs leading to increased quarterly losses. Encouragingly, net cash flow was positive with adjusted net cash of PLN33.3m at Q123. Progress has been underpinned by new development contracts with the potential to extend existing markets or increase addressable segments.
Edison Investment Research Limited Edison Investment Research Limited: Creotech Instruments (CRI): Initiation – A leader in EEC spacetech and quantum 18-Apr-2023 / 07:15 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 18 April 2023 Creotech Instruments (CRI): Initiation – A leader in EEC spacetech and quantum Creotech Instruments is Poland’s leading space tech company, founded in 2012 by alumni of CERN, the European Organization for Nuclear Research. In July 2022, the company’s shares transferred to the main market of the Warsaw ...
Edison Investment Research Limited Thrace Plastics (PLAT): Initiation – Demonstrable core growth as COVID-19 subsides 18-Apr-2023 / 07:15 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 18 April 2023 Thrace Plastics (PLAT): Initiation – Demonstrable core growth as COVID-19 subsides Thrace Plastics’ FY22e core product PBT (excluding the c €5m pandemic-related personal protective equipment (PPE) boost and one-off financial income of €4.6m) should be well ahead of pre-COVID levels. Future growth from the more sustainable core produc...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.